Mukka Proteins corrects investment consideration to ₹66.25 Lakh for Swachha Eco Solutions
Mukka Proteins Limited corrected its investment disclosure for Swachha Eco Solutions Private Limited (SESPL). The total consideration was revised to ₹66.25 Lakh from ₹64.93 Lakh due to a calculation error. The number of shares (26,500) and price per share (₹250) remain unchanged. The acquisition, aimed at expanding the Waste Management segment, is expected to be completed by 31st December 2026.
The correction of a calculation error in the total consideration amount, without any change in the number of shares, price, or percentage of shareholding, has a minimal impact on the company's overall business or financials.
The announcement is a clarification of a previous disclosure due to a calculation error, with no change in the core terms of the investment. Therefore, the sentiment is neutral.
Mukka Proteins Limited has issued a clarification regarding its earlier intimation dated 12th August 2026, concerning an investment in Swachha Eco Solutions Private Limited (SESPL). The company stated that due to an inadvertent calculation error, the total consideration for the proposed acquisition of 26,500 equity shares of SESPL at ₹250 per share was incorrectly reported as ₹64,92,500.
The correct total consideration is ₹66,25,000. The company emphasized that there is no change in the number of shares to be acquired, the price per share, or the percentage of shareholding. The original disclosure mentioned the acquisition of 26,500 equity shares at ₹250 per share.
The Board of Directors of Mukka Proteins Limited, in their meeting held on 12th August 2026, had approved a strategic investment in SESPL by acquiring equity shares not exceeding ₹64,92,500, which would represent 25.98% of SESPL's issued and paid-up equity share capital. SESPL is involved in the collection, treatment, and disposal of all types of waste. The company's strategic investment plan aims to expand its Waste Management segment.
The acquisition of 26,500 equity shares of SESPL, with a face value of ₹10 each, at a price of ₹250 per share, for a total consideration of ₹66,25,000 (as corrected), will result in Mukka Proteins holding 25.98% of SESPL's share capital. The indicative time period for the completion of the acquisition is 31st December 2026. Mukka Proteins Limited regrets the inadvertent error in the previous disclosure.
What to do with a filing like this
Mukka Proteins Limited filed this with the NSE as a statutory disclosure, categorised under other corporate actions. It is a primary document, not a recommendation, and the desk marks it low impact, the band that almost never moves a portfolio on its own.
That call is the part a filing cannot make for you. On RealCase, SEBI-registered research analysts and investment advisers read announcements like this one and turn the ones that matter into actions inside their model portfolios: a change in weight, a hold, or nothing at all. You are not left working out which of the roughly 250 filings published each day needs a response. The portfolio you follow is updated when a filing actually warrants it, with the reason written down.
See the model portfoliosA plain-language summary of a public exchange filing by Mukka Proteins Limited. Read the original for the full detail.